137 related articles for article (PubMed ID: 36106595)
1. Effect of the sequence of pull of bone marrow aspirates on plasma cell quantification in plasma cell proliferative disorders.
Jain G; Das N; Gajendra S; Gangwar SP; Gupta R; Mallik S; Sharma A; Kumar L; Upadhyay AD
Int J Lab Hematol; 2022 Oct; 44(5):837-845. PubMed ID: 36106595
[TBL] [Abstract][Full Text] [Related]
2. Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.
Cogbill CH; Spears MD; Vantuinen P; Harrington AM; Olteanu H; Kroft SH
Int J Lab Hematol; 2015 Dec; 37(6):797-808. PubMed ID: 26224420
[TBL] [Abstract][Full Text] [Related]
3. Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma.
Stifter S; Babarović E; Valković T; Seili-Bekafigo I; Stemberger C; Nacinović A; Lucin K; Jonjić N
Diagn Pathol; 2010 May; 5():30. PubMed ID: 20482792
[TBL] [Abstract][Full Text] [Related]
4. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M
Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients.
Joshi R; Horncastle D; Elderfield K; Lampert I; Rahemtulla A; Naresh KN
J Clin Pathol; 2008 Feb; 61(2):213-6. PubMed ID: 17526802
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method.
Manasanch EE; Salem DA; Yuan CM; Tageja N; Bhutani M; Kwok M; Kazandjian D; Carter G; Steinberg SM; Zuchlinski D; Mulquin M; Calvo K; Maric I; Roschewski M; Korde N; Braylan R; Landgren O; Stetler-Stevenson M
Leuk Lymphoma; 2015 May; 56(5):1416-24. PubMed ID: 25263319
[TBL] [Abstract][Full Text] [Related]
7. [Optimizing plasma cell content in bone marrow aspirates].
Hoffmann T; Favre G; Gratwohl A; Passweg J; Mathys S; Borel J; Speck B; Tichelli A
Schweiz Med Wochenschr; 1998 Oct; 128(42):1611-3. PubMed ID: 9824893
[TBL] [Abstract][Full Text] [Related]
8. Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment response.
Demyanets S; Kaider A; Simonitsch-Klupp I; Bayer G; Subasic A; Thalhammer R; Esterbauer H; Krauth MT; Agis H; Reiter T; Schwarzinger I
Ann Hematol; 2020 Nov; 99(11):2599-2609. PubMed ID: 32935190
[TBL] [Abstract][Full Text] [Related]
9. Polychromatic flow cytometry is more sensitive than microscopy in detecting small monoclonal plasma cell populations.
Tran DN; Smith SA; Brown DA; Parker AJ; Joseph JE; Armstrong N; Sewell WA
Cytometry B Clin Cytom; 2017 Mar; 92(2):136-144. PubMed ID: 27416483
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
Sezer O; Heider U; Zavrski I; Possinger K
Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
[TBL] [Abstract][Full Text] [Related]
11. Detection of lymphoid neoplasms in bone marrow by flow cytometric analysis and comparison to bone marrow aspiration and biopsy.
Promsuwicha O; Songmuang W; Auewarakul CU
J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S210-5. PubMed ID: 23590044
[TBL] [Abstract][Full Text] [Related]
12. Role of fine-needle aspirate immunophenotyping by flow cytometry in rapid diagnosis of lymphoproliferative disorders.
Gupta R; Naseem S; Kashyap R; Paul L
Diagn Cytopathol; 2007 Jul; 35(7):381-5. PubMed ID: 17580342
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of bone marrow biopsy and smear efficacy in patients with multiple myeloma].
Su JY; Tao Y; Liu YZ; Zhou LY; Yang LP; Liu H; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1389-91. PubMed ID: 23257439
[TBL] [Abstract][Full Text] [Related]
14. Methodological considerations for the high sensitivity detection of multiple myeloma measurable residual disease.
Soh KT; Tario JD; Hahn TE; Hillengass J; McCarthy PL; Wallace PK
Cytometry B Clin Cytom; 2020 Mar; 98(2):161-173. PubMed ID: 31868315
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric Flow Cytometry in the Evaluation of Plasma Cell Proliferative Disorders: Current Paradigms for Clinical Practice.
Gupta R; Jevremovic D; Mathew SJ; Kumar S
Clin Lymphoma Myeloma Leuk; 2024 Mar; 24(3):e88-e95. PubMed ID: 38142203
[TBL] [Abstract][Full Text] [Related]
16. Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patients with multiple myeloma.
Terpstra WE; Lokhorst HM; Blomjous F; Meuwissen OJ; Dekker AW
Br J Haematol; 1992 Sep; 82(1):46-9. PubMed ID: 1419801
[TBL] [Abstract][Full Text] [Related]
17. Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry.
Al-Quran SZ; Yang L; Magill JM; Braylan RC; Douglas-Nikitin VK
Hum Pathol; 2007 Dec; 38(12):1779-87. PubMed ID: 17714757
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of plasma cells in bone marrow aspirates by flow cytometric analysis compared with morphologic assessment.
Smock KJ; Perkins SL; Bahler DW
Arch Pathol Lab Med; 2007 Jun; 131(6):951-5. PubMed ID: 17550325
[TBL] [Abstract][Full Text] [Related]
19. Value of bone marrow imprint smears in early diagnosis of bone marrow pathologies.
Tilak V; Das S; Bundhun S
J Clin Diagn Res; 2014 Nov; 8(11):FC01-3. PubMed ID: 25584225
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.
Rago A; Grammatico S; Za T; Levi A; Mecarocci S; Siniscalchi A; De Rosa L; Felici S; Bongarzoni V; Piccioni AL; La Verde G; Pisani F; Franceschini L; Paviglianiti AL; Caravita T; Petrucci MT; De Stefano V; Cimino G;
Cancer; 2012 Nov; 118(22):5544-9. PubMed ID: 22786730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
